{
  "scenario_id": "pharmaceuticals_supply_chain_traceability_2025",
  "context": "Global pharmaceutical company implementing blockchain-based supply chain traceability for drug authenticity verification, 12000 employees, $12B revenue, responding to counterfeit drug crisis",
  "stakeholders": {
    "requester": "VP Supply Chain",
    "approvers": [
      "CEO",
      "Chief Compliance Officer",
      "CFO"
    ],
    "influencers": [
      "Head of Regulatory Affairs",
      "VP Manufacturing",
      "Chief Information Officer",
      "Supplier Network"
    ]
  },
  "request": {
    "amount": "$45M",
    "purpose": "Implementation of blockchain traceability system across global supply chain",
    "urgency": "high",
    "justification": "Prevent counterfeit drugs and ensure patient safety with projected $200M cost savings from reduced recalls"
  },
  "decision_process": [
    {
      "stage": "pilot_program",
      "duration": "6 weeks",
      "activities": [
        "Blockchain platform evaluation",
        "Pilot supplier onboarding",
        "Technical feasibility testing"
      ],
      "outcome": "Pilot successful with 95% traceability accuracy"
    },
    {
      "stage": "regulatory_assessment",
      "duration": "8 weeks",
      "activities": [
        "FDA guidance review",
        "International compliance analysis",
        "Data privacy framework development"
      ],
      "outcome": "Regulatory compliant solution with approved data handling protocols"
    },
    {
      "stage": "supplier_integration",
      "duration": "10 weeks",
      "activities": [
        "Supplier capability assessment",
        "Integration planning",
        "Change management strategy"
      ],
      "outcome": "80% supplier readiness with comprehensive training program"
    },
    {
      "stage": "business_case_validation",
      "duration": "4 weeks",
      "activities": [
        "ROI analysis",
        "Risk assessment",
        "Executive presentation"
      ],
      "outcome": "Approved with phased implementation approach"
    }
  ],
  "business_impact": {
    "expected_savings": "$200M",
    "projected_recall_reduction": "70%",
    "risk_factors": [
      "Supplier adoption resistance",
      "Technology integration complexity",
      "Regulatory changes"
    ],
    "strategic_alignment": "Enhances product authenticity and patient safety while reducing compliance costs"
  }
}